Effect of postoperative chemotherapy on the serum alpha-fetoprotein level in hepatoblastoma

Journal of Pediatric Surgery

Volumn 39, Issue 12, 2004, Pages 1775-1778

  Kubota, Masayuki ^a   Yagi, Minoru ^b   Kanada, Satoshi ^a   Yamazaki, Satoru ^a   Tanaka, Shinji ^a   Asami, Keiko ^b   Ogawa, Atsushi ^b   Watanabe, Akihiro ^b   Iwabuchi, Haruko ^b   Kaneko, Michio ^c   Saida, Yukihisa ^c  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Niigata Cancer Center   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

alpha fetoprotein; chemotherapy; Hepatoblastoma

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PIRARUBICIN;

ARTICLE; BRAIN DISEASE; CANCER SURGERY; CASE REPORT; CHEMOTHERAPY; FOLLOW UP; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; POSTOPERATIVE CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE;

ALPHA-FETOPROTEINS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; POSTOPERATIVE CARE;

EID: 19944412482     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2004.08.038     Document Type: Article

References (11)

1. Abelev G.I. Alpha-fetoprotein 25 years of study. Tumor Biol. 10:1989;63-74
2. Tsuchida Y., Ikeda H., Suzuki N., et al. A case of well-differentiated, fetal- type hepatoblastoma with very low serum alpha-fetoprotein. J Pediatr Surg. 34:1999;1762-1764
3. Blouin P., Brugieres L., Tabone M.D., et al. Carboplatin-epirubicin regimen for the treatment of hepatoblastoma. Pediatr Blood Cancer. 42:2004;149-154
4. Hata Y. The clinical features and prognosis of hepatoblastoma Follow-up studies done on pediatric tumors enrolled in the Japanese Pediatric Tumor Registry between 1971 and 1980. Part I. Committee of Malignant Tumors, Japanese Society of Pediatric Surgeons. Jpn J Surg. 20:1990;498-502
5. Sasaki F., Matsunaga T., Iwafuchi M., et al. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1 A report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg. 37:2002;851-856
6. Fuchs J., Rydzynski J., Von Schweinitz D., et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma A report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer. 95:2002;172-182
7. Aoyagi Y., Suzuki Y., Isemura M., et al. The fucosylation index of alpha- fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer. 61:1988;769-774
8. Tsuchida Y., Kaneko M., Fukui M., et al. Three different types of alpha- fetoprotein in the diagnosis of malignant solid tumors Use of a sensitive lectin-affinity immunoelectrophoresis. J Pediatr Surg. 24:1989;350-355
9. Tsuchida Y., Honna T., Fukui M., et al. The ratio of fucosylation of alpha- fetoprotein in hepatoblastoma. Cancer. 63:1989;2174-2176
10. Tsuchida Y., Terada M., Honna T., et al. The role of subfractionation of alpha-fetoprotein in the treatment of pediatric surgical patients. J Pediatr Surg. 32:1997;514-517
11. Nakabayashi H., Taketa K., Yamane T., et al. Hormonal control of alpha-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium. Cancer Res. 45:1985;6379-6383